10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,681 | +2.2% | 10,465 | +38.4% | 0.01% | 0.0% |
| Q2 2023 | $422,262 | +8.1% | 7,562 | +8.0% | 0.01% | +12.5% |
| Q1 2023 | $390,530 | +38.3% | 7,000 | -9.7% | 0.01% | +33.3% |
| Q4 2022 | $282,410 | -48.7% | 7,750 | -59.8% | 0.01% | -50.0% |
| Q3 2022 | $550,000 | -40.5% | 19,299 | -5.6% | 0.01% | -33.3% |
| Q2 2022 | $925,000 | -42.2% | 20,442 | -2.7% | 0.02% | -28.0% |
| Q1 2022 | $1,599,000 | -51.0% | 21,015 | -4.0% | 0.02% | -46.8% |
| Q4 2021 | $3,261,000 | +15.1% | 21,889 | +12.5% | 0.05% | +9.3% |
| Q3 2021 | $2,832,000 | -7.3% | 19,454 | +24.6% | 0.04% | -4.4% |
| Q2 2021 | $3,056,000 | +58.0% | 15,607 | +46.1% | 0.04% | +50.0% |
| Q1 2021 | $1,934,000 | +200.3% | 10,685 | +134.8% | 0.03% | +172.7% |
| Q4 2020 | $644,000 | – | 4,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |